IL-4Ra signaling is required for thymic stromal lymphopoietin (TSLP)-induced type 2 airway inflammation

S. Srivatsan (Tarrytown, United States of America), G. Scott (Tarrytown, United States of America), D. Birchard (Tarrytown, United States of America), J. Allinne (Tarrytown, United States of America), L. Ben (Tarrytown, United States of America), A. Murphy (Tarrytown, United States of America), M. Sleeman (Tarrytown, United States of America), J. Orengo (Tarrytown, United States of America)

Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Srivatsan (Tarrytown, United States of America), G. Scott (Tarrytown, United States of America), D. Birchard (Tarrytown, United States of America), J. Allinne (Tarrytown, United States of America), L. Ben (Tarrytown, United States of America), A. Murphy (Tarrytown, United States of America), M. Sleeman (Tarrytown, United States of America), J. Orengo (Tarrytown, United States of America). IL-4Ra signaling is required for thymic stromal lymphopoietin (TSLP)-induced type 2 airway inflammation. 2833

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Thymic stromal lymphopoietin promotes asthmatic airway remodeling in human lung fibroblast cells through stat3 signaling pathway
Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2012

Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: the role of thymic stromal lymphopoietin
Source: International Congress 2018 – Roles of innate lymphoid cells in asthma
Year: 2018


FcepsilonRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells
Source: Eur Respir J 2009; 33: 425-435
Year: 2009



Vanadium pentoxide induced epithelial innate cytokines IL-25, IL-33, and thymic stromal lymphopoietin (TSLP) through activating MAPK pathway
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018

Thymic stromal lymphopoietin (TSLP), an innate immunity initiator of Th2 inflammatory responses, is induced by viral stimuli in asthmatic epithelium.
Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment
Year: 2008

Thymic stromal lymphopoietin, but not ezrin, could be an early biomarker of airway epithelial dysfunction in acute allergic asthma
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019

Blockade of thymic stromal lymphopoietin receptor (TSLPR) reduces atopic inflammation in a cynomolgus monkey model of asthma
Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2012

Inhaled antibodies: targeting tumour necrosis factor receptor 1 and thymic stromal lymphopoietin
Source: International Congress 2019 – Inhaled medicines and biological therapies in the current era of systemic treatments
Year: 2019


YS3: Thymic stromal lymphopoietin is a central regulator of anti-viral CD8+ T cell responses
Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease
Year: 2011

Peripheral blood TSLP (thymic stromal lymphopoietin) in children as a biomarker?
Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma
Year: 2021


Serum thymic stromal lymphopoietin level depends on allergic profile in pediatric asthma
Source: Virtual Congress 2021 – Paediatric lung disease: novel mechanisms, methods and translational studies
Year: 2021



IL-25 secreted from epithelial cells has the potential to promote airway remodeling in asthma
Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Year: 2012

Current evidence of epidermal barrier dysfunction and thymic stromal lymphopoietin in the atopic march
Source: Eur Respir Rev 2014; 23: 292-298
Year: 2014



ILC2 cells from severe allergic and eosinophilic asthma demonstrate increased expression of TSLP receptor (TSLPR) and enhanced proliferative capacity.
Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Year: 2021


Analysing disease-specific variants of thymic stromal lymphopoietin (TSLP) in asthma
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015

CD6 is expressed on human airway and blood innate lymphoid cells (ILCs) and is upregulated by epithelial alarmins IL-33 and TSLP
Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes
Year: 2020


IL-8 and TSLP production as markers of bronchial epithelial cell activation in IL-17A mediated airway inflammation in COPD: Role of tiotropium
Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung
Year: 2013

Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells
Source: Eur Respir J 2012; 39: 439-445
Year: 2012



Activation of bone morphogenetic protein(BMP)/Smad signaling in bronchial epithelial cells during airway inflammation
Source: Eur Respir J 2002; 20: Suppl. 38, 372s
Year: 2002